AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

How to Best Treat Anterior Cruciate Ligament Injuries

RecruitingNAAges 16 Years - 50 YearsAllUniversity Hospital, Akershus
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The project is a pragmatic registry-based RCT aiming to investigate ACL injury treatment. Study results will help fill knowledge gaps, facilitate shared decision making and strengthen patient treatment. Included patients will be randomized to (1) early ACL surgery followed by rehabilitation or (2) active rehabilitation with optional delayed surgery if indicated. Randomization and data collection is conducted through the Norwegian National Knee Ligament Registry (NNKLR) which is a well established population based ACL registry. Participation is based on informed consent to participate in the NNKLR and the registry-based RCT. The study uses the platform and outcome measures of the NNKLR to collect and measure data. The data will be stored as usual in the NNKLR, but RCT specific data will be exported for analysis and stored inTjenester for sensitive data (TSD). Data collected in NNKLR are

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients who have sustained an acute ACL injury (must be possible to perform the "early surgery" treatment option within 12 weeks) * Age 16-50 years and skeletally mature * No previous surgery in the index knee or knee injury which influences rehabilitation * Patient capable to undergo both surgery and rehabilitation Exclusion Criteria: โ€ข Elite athletes (Tegner 10) in pivoting sports and patients with additional knee injuries warranting repair
๐Ÿ’Š

What it tests

  • Early ACL reconstruction
  • Active rehabilitation
๐Ÿ“

Where

2 sites
Orthopedic Department, Akershus University Hospital
Lรธrenskog, Norway
Orthopedic division, Oslo University Hospital
Oslo, Norway
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy